{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:56:29Z","timestamp":1793228189230,"version":"4.5.0"},"reference-count":454,"publisher":"SAGE Publications","issue":"s1","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,6,12]]},"DOI":"10.3233\/jad-179941","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T07:16:16Z","timestamp":1529306176000},"page":"S567-S610","source":"Crossref","is-referenced-by-count":837,"title":["The Amyloid-\u03b2 Oligomer Hypothesis: Beginning of the Third Decade"],"prefix":"10.1177","volume":"64","author":[{"given":"Erika N.","family":"Cline","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Cognitive Neurology and Alzheimer\u2019s Disease Center, International Institute for Nanotechnology, and Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00edra Assun\u00e7\u00e3o","family":"Bicca","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Cognitive Neurology and Alzheimer\u2019s Disease Center, International Institute for Nanotechnology, and Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Viola","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Cognitive Neurology and Alzheimer\u2019s Disease Center, International Institute for Nanotechnology, and Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Cognitive Neurology and Alzheimer\u2019s Disease Center, International Institute for Nanotechnology, and Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-179941_ref1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00005072-199411000-00011","article-title":"Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease","volume":"53","author":"Frackowiak","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-179941_ref2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1006\/bbrc.1994.2580","article-title":"Purification and characterization of brain clusterin","volume":"204","author":"Oda","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-179941_ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1995.1080","article-title":"Clusterin (Apoj) alters the aggregation of amyloid beta-peptide (A\u03b2(1-42)) and forms slowly sedimenting A\u03b2 complexes that cause oxidative stress","volume":"136","author":"Oda","year":"1995","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-179941_ref4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/alzrt226","article-title":"Amyloid beta-protein oligomers and Alzheimer\u2019s disease","volume":"5","author":"Hayden","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-179941_ref6","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer\u2019s disease-affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.3233\/JAD-179941_ref8","doi-asserted-by":"crossref","first-page":"32895","DOI":"10.1074\/jbc.M109.000208","article-title":"Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) asbly from Alzheimer disease brains","volume":"284","author":"Noguchi","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awq065","article-title":"The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia","volume":"133","author":"Mc Donald","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref10","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","article-title":"Progressive accumulation of amyloid-beta oligomers in Alzheimer\u2019s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins","volume":"277","author":"Pham","year":"2010","journal-title":"FEBS J"},{"key":"10.3233\/JAD-179941_ref11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","article-title":"Temporal memory deficits in Alzheimer\u2019s mouse models: Rescue by genetic deletion of BACE1","volume":"23","author":"Ohno","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-179941_ref12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","article-title":"Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls","volume":"73","author":"Esparza","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref13","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-beta oligomers in ageing and Alzheimer\u2019s disease","volume":"136","author":"Lesne","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","article-title":"Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome","volume":"125","author":"Gyure","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.3233\/JAD-179941_ref16","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer\u2019s-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","article-title":"A new amyloid beta variant favoring oligomerization in Alzheimer\u2019s-type dementia","volume":"63","author":"Tomiyama","year":"2008","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2353\/ajpath.2009.080480","article-title":"The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells","volume":"174","author":"Nishitsuji","year":"2009","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179941_ref19","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1523\/JNEUROSCI.5825-09.2010","article-title":"A mouse model of amyloid beta oligomers: Their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo","volume":"30","author":"Tomiyama","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000330017","article-title":"Clinical course of patients with familial early-onset Alzheimer\u2019s disease potentially lacking senile plaques bearing the E693Delta mutation in amyloid precursor protein","volume":"32","author":"Shimada","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-179941_ref21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/13506129.2011.580399","article-title":"Structural dynamics of the DeltaE22 (Osaka) familial Alzheimer\u2019s disease-linked amyloid beta-protein","volume":"18","author":"Inayathullah","year":"2011","journal-title":"Amyloid"},{"key":"10.3233\/JAD-179941_ref22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2169\/internalmedicine.54.3021","article-title":"A second pedigree with amyloid-less familial Alzheimer\u2019s disease harboring an identical mutation in the amyloid precursor protein gene (E693delta)","volume":"54","author":"Kutoku","year":"2015","journal-title":"Intern Med"},{"key":"10.3233\/JAD-179941_ref23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ana.22052","article-title":"Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers","volume":"68","author":"Gandy","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref24","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1021\/bi972029u","article-title":"Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red","volume":"37","author":"Podlisny","year":"1998","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ab.2004.08.014","article-title":"Alzheimer\u2019s beta-peptide oligomer formation at physiologic concentrations","volume":"335","author":"LeVine","year":"2004","journal-title":"Anal Biochem"},{"key":"10.3233\/JAD-179941_ref26","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1385\/JMN:20:3:305","article-title":"Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer\u2019s disease drug candidate screening","volume":"20","author":"Chang","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-179941_ref28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer\u2019s disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref29","doi-asserted-by":"crossref","first-page":"950783","DOI":"10.1155\/2013\/950783","article-title":"Breaking the code of amyloid-beta oligomers","volume":"2013","author":"Lesne","year":"2013","journal-title":"Int J Cell Biol"},{"key":"10.3233\/JAD-179941_ref30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13506120500106958","article-title":"Neurotoxic protein oligomers\u2013what you see is not always what you get","volume":"12","author":"Bitan","year":"2005","journal-title":"Amyloid"},{"key":"10.3233\/JAD-179941_ref31","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","article-title":"Self-assembly of Abeta(1-42) into globular neurotoxins","volume":"42","author":"Chromy","year":"2003","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref32","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1073\/pnas.0409336102","article-title":"Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer\u2019s disease","volume":"102","author":"Georganopoulou","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","article-title":"Amyloid biomarkers in Alzheimer\u2019s disease","volume":"36","author":"Blennow","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-179941_ref34","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1523\/JNEUROSCI.1675-13.2014","article-title":"A sensitive abeta oligomer assay discriminates Alzheimer\u2019s and aged control cerebrospinal fluid","volume":"34","author":"Savage","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-015-0100-y","article-title":"A highly sensitive novel immunoassay specifically detects low levels of soluble Abeta oligomers in human cerebrospinal fluid","volume":"7","author":"Yang","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST0331087","article-title":"The role of cell-derived oligomers of Abeta in Alzheimer\u2019s disease and avenues for therapeutic intervention","volume":"33","author":"Walsh","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-179941_ref37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179941_ref38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.neurobiolaging.2009.11.007","article-title":"Cognitive effects of cell-derived and synthetically derived Abeta oligomers","volume":"32","author":"Reed","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref39","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1523\/JNEUROSCI.0482-13.2013","article-title":"Memantine rescues transient cognitive impairment caused by high-molecular-weight abeta oligomers but not the persistent impairment induced by low-molecular-weight oligomers","volume":"33","author":"Figueiredo","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","article-title":"Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers","volume":"572","author":"Townsend","year":"2006","journal-title":"J Physiol"},{"key":"10.3233\/JAD-179941_ref41","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.5161-07.2008","article-title":"Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: Prevention by systemic passive immunization","volume":"28","author":"Klyubin","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179941_ref44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref45","doi-asserted-by":"crossref","first-page":"e53117","DOI":"10.1371\/journal.pone.0053117","article-title":"Alzheimer\u2019s disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-beta peptide injection in rats","volume":"8","author":"Zussy","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref46","doi-asserted-by":"crossref","first-page":"13629","DOI":"10.1523\/JNEUROSCI.1353-14.2014","article-title":"Alzheimer\u2019s disease-like pathology induced by amyloid-beta oligomers in nonhuman primates","volume":"34","author":"Forny-Germano","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref47","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.3233\/JAD-179941_ref49","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1074\/jbc.M110.135244","article-title":"Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity","volume":"286","author":"Maezawa","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref50","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","article-title":"The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer\u2019s disease","volume":"32","author":"Larson","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref51","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref52","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines","volume":"30","author":"Zempel","year":"2010","journal-title":"JNeurosci"},{"key":"10.3233\/JAD-179941_ref53","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179941_ref54","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","article-title":"Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses","volume":"25","author":"Roselli","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref55","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref56","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1073\/pnas.0901229106","article-title":"Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta","volume":"106","author":"Pigino","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref57","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neurobiolaging.2009.05.012","article-title":"beta-Amyloid impairs axonal BDNF retrograde trafficking","volume":"32","author":"Poon","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref58","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","article-title":"N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer\u2019s toxic amyloid-beta peptide oligomers","volume":"115","author":"Decker","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref59","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1046\/j.1471-4159.2000.0751977.x","article-title":"Reversible inactivation of superoxide-sensitive aconitase in Abeta1-42-treated neuronal cell lines","volume":"75","author":"Longo","year":"2000","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref60","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1074\/jbc.M206745200","article-title":"Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation","volume":"278","author":"Sponne","year":"2003","journal-title":"JBiol Chem"},{"key":"10.3233\/JAD-179941_ref61","doi-asserted-by":"crossref","first-page":"35789","DOI":"10.1074\/jbc.C500238200","article-title":"Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia","volume":"280","author":"Tabner","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref62","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref63","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jnr.22640","article-title":"Intraneuronal amyloid beta oligomers cause cell death via endoplasmic reticulum stress, endosomal\/lysosomal leakage, and mitochondrial dysfunction in vivo","volume":"89","author":"Umeda","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-179941_ref64","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jnr.21648","article-title":"ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation","volume":"86","author":"Resende","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-179941_ref65","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","article-title":"Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}","volume":"284","author":"Zhao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref66","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer\u2019s-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref67","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref68","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(97)01318-8","article-title":"Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release","volume":"785","author":"Hu","year":"1998","journal-title":"Brain Res"},{"key":"10.3233\/JAD-179941_ref69","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.neurobiolaging.2011.01.007","article-title":"Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer\u2019s disease","volume":"33","author":"Ferretti","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref70","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1471-4159.2006.04015.x","article-title":"Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells","volume":"98","author":"Heinitz","year":"2006","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref71","doi-asserted-by":"crossref","first-page":"19377","DOI":"10.1074\/jbc.M111.321448","article-title":"Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-beta peptide oligomers","volume":"287","author":"Nunes-Tavares","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11064-011-0592-1","article-title":"BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid beta-induced toxicity in cultured rat septal neurons","volume":"37","author":"Kitiyanant","year":"2012","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-179941_ref73","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1091\/mbc.e17-06-0416","article-title":"Neuroprotective astrocyte-derived insulin\/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Abeta oligomers","volume":"28","author":"Pitt","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.3233\/JAD-179941_ref74","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE4 and Abeta oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref75","doi-asserted-by":"crossref","first-page":"16937","DOI":"10.1074\/jbc.M113.463711","article-title":"beta-Amyloid (Abeta) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1","volume":"288","author":"Poon","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref76","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12634","article-title":"Epigenetic regulation by G9a\/GLP complex ameliorates amyloid-beta 1-42 induced deficits in long-term plasticity and synaptic tagging\/capture in hippocampal pyramidal neurons","volume":"16","author":"Sharma","year":"2017","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-179941_ref77","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-150838","article-title":"Inhibition of histone deacetylase 3 restores amyloid-beta oligomer-induced plasticity deficit in hippocampal CA1 pyramidal neurons","volume":"51","author":"Krishna","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref78","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1021\/cn500323q","article-title":"Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function","volume":"6","author":"Mastroeni","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-179941_ref79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-130101","article-title":"Soluble oligomers of amyloid-beta cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake","volume":"36","author":"Hodgson","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref80","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.neurobiolaging.2012.12.028","article-title":"Disruption of neocortical histone H3 homeostasis by soluble Abeta: Implications for Alzheimer\u2019s disease","volume":"34","author":"Lithner","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref81","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1523\/JNEUROSCI.2441-08.2008","article-title":"Abeta oligomers induce neuronal cell cycle events in Alzheimer\u2019s disease","volume":"28","author":"Varvel","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref82","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1172\/JCI39716","article-title":"NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease","volume":"119","author":"Varvel","year":"2009","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-179941_ref83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-4-14","article-title":"The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events","volume":"4","author":"Bhaskar","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-179941_ref84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1096\/fj.01-0987fje","article-title":"Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein","volume":"17","author":"Kim","year":"2003","journal-title":"FASEB J"},{"key":"10.3233\/JAD-179941_ref85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1326-9-41","article-title":"Altered synaptic structure in the hippocampus in a mouse model of Alzheimer\u2019s disease with soluble amyloid-beta oligomers and no plaque pathology","volume":"9","author":"Price","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-179941_ref86","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer\u2019s-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref88","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","article-title":"Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models","volume":"282","author":"Cheng","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","article-title":"Monoclonal antibodies that target pathological assemblies of Abeta","volume":"100","author":"Lambert","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref90","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jmb.2008.09.068","article-title":"Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells","volume":"384","author":"Zameer","year":"2008","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-179941_ref91","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm1234","article-title":"Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo","volume":"11","author":"Klyubin","year":"2005","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179941_ref92","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-122419","article-title":"Brain transit and ameliorative effects of intranasally delivered anti-amyloid-beta oligomer antibody in 5XFAD mice","volume":"35","author":"Xiao","year":"2013","journal-title":"JAlzheimers Dis"},{"key":"10.3233\/JAD-179941_ref93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15672050113106660176","article-title":"Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer\u2019s disease","volume":"11","author":"Zhao","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-179941_ref94","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/jnc.14118","article-title":"A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-beta oligomers","volume":"142","author":"Sebollela","year":"2017","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref95","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref96","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nnano.2014.254","article-title":"Towards non-invasive diagnostic imaging of early-stage Alzheimer\u2019s disease","volume":"10","author":"Viola","year":"2015","journal-title":"Nat Nanotechnol"},{"key":"10.3233\/JAD-179941_ref97","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref98","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.3233\/JAD-179941_ref99","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.38.11.1682","article-title":"Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer\u2019s disease","volume":"38","author":"Crystal","year":"1988","journal-title":"Neurology"},{"key":"10.3233\/JAD-179941_ref100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: Few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/alzrt272","article-title":"Targeting the proper amyloid-beta neuronal toxins: A path forward for Alzheimer\u2019s disease immunotherapeutics","volume":"6","author":"Goure","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ana.24188","article-title":"A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease","volume":"76","author":"Karran","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref103","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJMe1313943","article-title":"Antiamyloid therapy for Alzheimer\u2019s disease\u2013are we on the right road?","volume":"370","author":"Karran","year":"2014","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-179941_ref104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer\u2019s disease patients","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179941_ref105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref106","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.3233\/JAD-179941_ref107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-017-0293-3","article-title":"Non-canonical soluble amyloid-beta aggregates and plaque buffering: Controversies and future directions for target discovery in Alzheimer\u2019s disease","volume":"9","author":"Brody","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-amyloid-beta monoclonal antibodies for Alzheimer\u2019s disease: Pitfalls and promise","volume":"83","author":"van Dyck","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-179941_ref109","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","article-title":"Targeting small Abeta oligomers: The solution to an Alzheimer\u2019s disease conundrum?","volume":"24","author":"Klein","year":"2001","journal-title":"Trends Neurosci"},{"issue":"Suppl 2","key":"10.3233\/JAD-179941_ref110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jnc.13632","article-title":"The amyloid cascade hypothesis: Are we poised for success or failure?","volume":"139","author":"Karran","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref111","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.trci.2017.04.005","article-title":"Phase II clinical trials of anti-amyloid beta antibodies: When is enough, enough?","volume":"3","author":"Gold","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-179941_ref112","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-179941_ref113","doi-asserted-by":"crossref","unstructured":"Le Couteur DG , Hunter S , Brayne C (2016) Solanezumab and the amyloid hypothesis for Alzheimer\u2019s disease, BMJ 355.","DOI":"10.1136\/bmj.i6771"},{"key":"10.3233\/JAD-179941_ref114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2016.21045","article-title":"Failed Alzheimer\u2019s trial does not kill leading theory of disease","volume":"540","author":"Abbott","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2015.00191","article-title":"Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-179941_ref116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt203","article-title":"On the subject of rigor in the study of amyloid beta-protein assembly","volume":"5","author":"Teplow","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref117","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer\u2019s disease: An emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179941_ref118","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/cn300122k","article-title":"Synapse-binding subpopulations of Abeta oligomers sensitive to peptide assembly blockers and scFv antibodies","volume":"3","author":"Velasco","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-179941_ref119","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.celrep.2015.05.021","article-title":"Quaternary structure defines a large class of amyloid-beta oligomers neutralized by sequestration","volume":"11","author":"Liu","year":"2015","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-179941_ref120","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1212\/NXI.0000000000000237","article-title":"Effective anti-Alzheimer Abeta therapy involves depletion of specific Abeta oligomer subtypes","volume":"3","author":"Knight","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.3233\/JAD-179941_ref121","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/brain\/awt375","article-title":"High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer\u2019s disease","volume":"137","author":"Dohler","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref122","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1074\/jbc.M115.643577","article-title":"Prion-protein-interacting amyloid-beta oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models","volume":"290","author":"Kostylev","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref123","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/acschemneuro.5b00229","article-title":"Soluble prion protein binds isolated low molecular weight amyloid-beta oligomers causing cytotoxicity inhibition","volume":"6","author":"Williams","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-179941_ref124","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","article-title":"The aqueous phase of Alzheimer\u2019s disease brain contains assemblies built from approximately 4 and approximately 7 kDa Abeta species","volume":"11","author":"Mc Donald","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179941_ref125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","article-title":"High-molecular weight Abeta oligomers and protofibrils are the predominant Abeta species in the native soluble protein fraction of the AD brain","volume":"16","author":"Upadhaya","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-179941_ref126","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000446283","article-title":"A study of Abeta oligomers in the temporal cortex and cerebellum of patients with neuropathologically confirmed Alzheimer\u2019s disease compared to aged controls","volume":"16","author":"Savioz","year":"2016","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-179941_ref127","doi-asserted-by":"crossref","first-page":"eaal2021","DOI":"10.1126\/scisignal.aal2021","article-title":"The amyloid-beta oligomer Abeta*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation","volume":"10","author":"Amar","year":"2017","journal-title":"Sci Signal"},{"key":"10.3233\/JAD-179941_ref128","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1523\/JNEUROSCI.1899-16.2016","article-title":"Soluble conformers of Abeta and tau alter selective proteins governing axonal transport","volume":"36","author":"Sherman","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20140219","article-title":"Abeta dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies","volume":"461","author":"O\u2019Malley","year":"2014","journal-title":"Biochem J"},{"key":"10.3233\/JAD-179941_ref130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-385883-2.00012-6","article-title":"Alzheimer\u2019s disease and the amyloid beta-protein","volume":"107","author":"Walsh","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-179941_ref131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/156720508786898433","article-title":"Is covalently crosslinked Abeta responsible for synaptotoxicity in Alzheimer\u2019s disease?","volume":"5","author":"Naylor","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-179941_ref132","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1038\/s41598-017-10422-x","article-title":"Diversity of amyloid-beta proteoforms in the Alzheimer\u2019s disease brain","volume":"7","author":"Wildburger","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-179941_ref133","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jalz.2016.03.011","article-title":"Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint","volume":"12","author":"Rudinskiy","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179941_ref134","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biocel.2016.08.037","article-title":"A critical concentration of N-terminal pyroglutamylated amyloid beta drives the misfolding of Ab1-42 into more toxic aggregates","volume":"79","author":"Galante","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3233\/JAD-179941_ref135","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/bi500587p","article-title":"Role of the fast kinetics of pyroglutamate-modified amyloid-beta oligomers in membrane binding and membrane permeability","volume":"53","author":"Lee","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref136","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1074\/jbc.M117.777839","article-title":"Structural and functional analyses of pyroglutamate-amyloid-beta-specific antibodies as a basis for Alzheimer immunotherapy","volume":"292","author":"Piechotta","year":"2017","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref137","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","article-title":"Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques","volume":"14","author":"Saido","year":"1995","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref138","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.ajpath.2013.01.053","article-title":"Abeta43 is the earliest-depositing Abeta species in APP transgenic mouse brain and is converted to Abeta41 by two active domains of ACE","volume":"182","author":"Zou","year":"2013","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179941_ref139","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1021\/bi500131a","article-title":"The C-terminal threonine of Abeta43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils","volume":"53","author":"Conicella","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15252\/emmm.201505952","article-title":"Generation and deposition of Abeta43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer\u2019s disease","volume":"8","author":"Kretner","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-179941_ref141","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1021\/bi5003053","article-title":"Secreted amyloid beta-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity","volume":"53","author":"Welzel","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref142","doi-asserted-by":"crossref","first-page":"14673","DOI":"10.1021\/jacs.5b07849","article-title":"N-terminal extensions retard Abeta42 fibril formation but allow cross-seeding and co-aggregation with Abeta42","volume":"137","author":"Szczepankiewicz","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.3233\/JAD-179941_ref143","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2013.10.084","article-title":"Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-beta","volume":"441","author":"Sugiki","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-179941_ref144","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00401-016-1546-0","article-title":"Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity","volume":"131","author":"Kumar","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref145","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awt362","article-title":"Biochemical stages of amyloid-beta peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease","volume":"137","author":"Rijal Upadhaya","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref146","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1074\/jbc.M110.181313","article-title":"Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses","volume":"286","author":"Matsumura","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref147","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1073\/pnas.1524807113","article-title":"High-speed atomic force microscopy reveals structural dynamics of amyloid beta1-42 aggregates","volume":"113","author":"Watanabe-Nakayama","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref148","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2016.06.122","article-title":"Structural differences between amyloid beta oligomers","volume":"477","author":"Breydo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-179941_ref149","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/jacs.7b10343","article-title":"Pathways of amyloid-beta aggregation depend on oligomer shape","volume":"140","author":"Barz","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.3233\/JAD-179941_ref150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","article-title":"Large soluble oligomers of amyloid beta-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate","volume":"37","author":"Yang","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref151","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref152","doi-asserted-by":"crossref","first-page":"8768","DOI":"10.1002\/chem.201601701","article-title":"Understanding amyloid-beta oligomerization at the molecular level: The role of the fibril surface","volume":"22","author":"Barz","year":"2016","journal-title":"Chemistry"},{"key":"10.3233\/JAD-179941_ref153","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/jacs.5b11913","article-title":"Amyloid beta-protein assembly and Alzheimer\u2019s disease: Dodecamers of Abeta42, but not of Abeta40, seed fibril formation","volume":"138","author":"Economou","year":"2016","journal-title":"JAm Chem Soc"},{"key":"10.3233\/JAD-179941_ref154","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"Koffie","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref155","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1111\/ejn.13442","article-title":"Human tau increases amyloid beta plaque size but not amyloid beta-mediated synapse loss in a novel mouse model of Alzheimer\u2019s disease","volume":"44","author":"Jackson","year":"2016","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-179941_ref156","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-beta","volume":"135","author":"Koffie","year":"2012","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref157","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Abeta generation in Alzheimer\u2019s disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref158","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid beta-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref159","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ab.2016.10.026","article-title":"Preparation of pure populations of covalently stabilized amyloid beta-protein oligomers of specific sizes","volume":"518","author":"Hayden","year":"2017","journal-title":"Anal Biochem"},{"key":"10.3233\/JAD-179941_ref160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/2051-5960-1-83","article-title":"A central role for dityrosine crosslinking of Amyloid-beta in Alzheimer\u2019s disease","volume":"1","author":"Al-Hilaly","year":"2013","journal-title":"Acta Neuropathol Commun"},{"issue":"Suppl 1","key":"10.3233\/JAD-179941_ref161","first-page":"S277","article-title":"The metal theory of Alzheimer\u2019s disease","volume":"33","author":"Bush","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref162","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1021\/acs.jpcb.7b02495","article-title":"Insights into formation and structure of Abeta oligomers cross-linked via tyrosines","volume":"121","author":"Zhang","year":"2017","journal-title":"J Phys Chem B"},{"key":"10.3233\/JAD-179941_ref163","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1039\/C4MT00323C","article-title":"Small angle X-ray scattering analysis of Cu-induced oligomers of the Alzheimer\u2019s amyloid beta peptide","volume":"7","author":"Ryan","year":"2015","journal-title":"Metallomics"},{"key":"10.3233\/JAD-179941_ref164","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1021\/bi0620961","article-title":"Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer\u2019s disease amyloid-beta peptide","volume":"46","author":"Smith","year":"2007","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-142136","article-title":"Amyloid-beta oligomers relate to cognitive decline in Alzheimer\u2019s disease","volume":"45","author":"Jongbloed","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref166","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1096\/fj.13-229666","article-title":"Brain interstitial oligomeric amyloid beta increases with age and is resistant to clearance from brain in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Takeda","year":"2013","journal-title":"FASEB J"},{"key":"10.3233\/JAD-179941_ref167","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00232-003-0638-7","article-title":"Architecture of the Alzheimer\u2019s A beta P ion channel pore","volume":"197","author":"Arispe","year":"2004","journal-title":"J Membr Biol"},{"key":"10.3233\/JAD-179941_ref168","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/03602532.2014.882354","article-title":"Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer\u2019s disease","volume":"46","author":"Drolle","year":"2014","journal-title":"Drug Metab Rev"},{"issue":"Suppl 1","key":"10.3233\/JAD-179941_ref169","first-page":"283","article-title":"Metals, membranes, and amyloid-beta oligomers: Key pieces in the Alzheimer\u2019s disease puzzle?S","volume":"33","author":"Watt","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bpc.2013.07.010","article-title":"Different effects of Alzheimer\u2019s peptide Abeta(1-40) oligomers and fibrils on supported lipid membranes","volume":"182","author":"Canale","year":"2013","journal-title":"Biophys Chem"},{"key":"10.3233\/JAD-179941_ref171","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jmb.2013.03.022","article-title":"Specific domains of Abeta facilitate aggregation on and association with lipid bilayers","volume":"425","author":"Yates","year":"2013","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-179941_ref172","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fphys.2013.00084","article-title":"Thermodynamically stable amyloid-beta monomers have much lower membrane affinity than the small oligomers","volume":"4","author":"Sarkar","year":"2013","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-179941_ref173","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1074\/jbc.M115.655183","article-title":"Amyloid-beta peptide Abeta3pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons","volume":"291","author":"Gunn","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref174","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1074\/jbc.M116.762526","article-title":"Ion channel formation by amyloid-beta42 oligomers but not amyloid-beta40 in cellular membranes","volume":"292","author":"Bode","year":"2017","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref175","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.1605104113","article-title":"Abeta42 assembles into specific beta-barrel pore-forming oligomers in membrane-mimicking environments","volume":"113","author":"Serra-Batiste","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref176","doi-asserted-by":"crossref","first-page":"31910","DOI":"10.1038\/srep31910","article-title":"Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells","volume":"6","author":"Drews","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-179941_ref177","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jnc.12390","article-title":"Mechanism of cholesterol-assisted oligomeric channel formation by a short Alzheimer beta-amyloid peptide","volume":"128","author":"Di Scala","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref178","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1567205011310020004","article-title":"Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer\u2019s disease","volume":"10","author":"Evangelisti","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-179941_ref179","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JAD-131406","article-title":"Plasma membrane injury depends on bilayer lipid composition in Alzheimer\u2019s disease","volume":"41","author":"Evangelisti","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref180","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.neurobiolaging.2013.06.001","article-title":"Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide","volume":"34","author":"Peters","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref181","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/ct300916f","article-title":"Mechanisms for the insertion of toxic, fibril-like beta-amyloid oligomers into the membrane","volume":"9","author":"Jang","year":"2013","journal-title":"J Chem Theory Comput"},{"key":"10.3233\/JAD-179941_ref182","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref183","doi-asserted-by":"crossref","first-page":"17112","DOI":"10.1074\/jbc.M116.720664","article-title":"Oligomers of amyloid beta prevent physiological activation of the cellular prion protein-metabotropic glutamate receptor 5 complex by glutamate in Alzheimer disease","volume":"291","author":"Haas","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref184","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref185","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179941_ref186","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref187","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1471-4159.2011.07225.x","article-title":"Amyloid-beta oligomers increase the localization of prion protein at the cell surface","volume":"117","author":"Caetano","year":"2011","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref188","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/cbic.201402377","article-title":"Single-molecule imaging reveals that small amyloid-beta(1-42) oligomers interact with the cellular prion protein (PrPC)","volume":"15","author":"Ganzinger","year":"2014","journal-title":"Chembiochem"},{"key":"10.3233\/JAD-179941_ref189","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.neurobiolaging.2014.11.019","article-title":"Alzheimer\u2019s Abeta interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity","volume":"36","author":"Peters","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref190","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/jnc.13166","article-title":"Dextran sulfate sodium inhibits amyloid-beta oligomer binding to cellular prion protein","volume":"134","author":"Aimi","year":"2015","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref191","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1074\/jbc.M112.400358","article-title":"Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1","volume":"288","author":"Rushworth","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref192","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1523\/JNEUROSCI.0277-04.2004","article-title":"Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice","volume":"24","author":"Chin","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref193","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.289.5486.1925","article-title":"Signal transduction through prion protein","volume":"289","author":"Mouillet-Richard","year":"2000","journal-title":"Science"},{"key":"10.3233\/JAD-179941_ref194","doi-asserted-by":"crossref","first-page":"e0125263","DOI":"10.1371\/journal.pone.0125263","article-title":"Nanoscale synaptic membrane mimetic allows unbiased high throughput screen that targets binding sites for Alzheimer\u2019s-associated Abeta oligomers","volume":"10","author":"Wilcox","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/emmm.201000088","article-title":"Prion protein in Alzheimer\u2019s pathogenesis: A hot and controversial issue","volume":"2","author":"Benilova","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-179941_ref196","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref197","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2012.04.034","article-title":"Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-beta (Abeta(1)(-)(4)(0)) administration in mice","volume":"215","author":"Rial","year":"2012","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-179941_ref198","doi-asserted-by":"crossref","first-page":"E4465","DOI":"10.1073\/pnas.1421182112","article-title":"Na, K-ATPase alpha3 is a death target of Alzheimer patient amyloid-beta assembly","volume":"112","author":"Ohnishi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref199","first-page":"45","article-title":"Alzheimer\u2019s toxic amyloid beta oligomers: Unwelcome visitors to the Na\/K ATPase alpha3 docking station","volume":"90","author":"DiChiara","year":"2017","journal-title":"Yale J Biol Med"},{"key":"10.3233\/JAD-179941_ref200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref201","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1074\/jbc.R115.702704","article-title":"Amyloid-beta receptors: The good, the bad, and the prion protein","volume":"291","author":"Jarosz-Griffiths","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref202","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.3233\/JAD-179941_ref203","doi-asserted-by":"crossref","first-page":"e111898","DOI":"10.1371\/journal.pone.0111898","article-title":"Alzheimer\u2019s therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref204","doi-asserted-by":"crossref","first-page":"e111899","DOI":"10.1371\/journal.pone.0111899","article-title":"Alzheimer\u2019s therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2\/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref205","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1074\/jbc.M707108200","article-title":"Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt\/beta-catenin signaling","volume":"283","author":"Magdesian","year":"2008","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref206","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1074\/jbc.M116.761189","article-title":"Interaction of amyloid-beta (Abeta) oligomers with neurexin 2alpha and neuroligin 1 mediates synapse damage and memory loss in mice","volume":"292","author":"Brito-Moreira","year":"2017","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref207","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/2211-5463.12056","article-title":"Identification of approved drugs that inhibit the binding of amyloid beta oligomers to ephrin type-B receptor 2","volume":"6","author":"Suzuki","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.3233\/JAD-179941_ref208","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1405803111","article-title":"Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer\u2019s disease","volume":"111","author":"Fu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref209","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1523\/JNEUROSCI.0862-13.2014","article-title":"In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer\u2019s disease model","volume":"34","author":"Vargas","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.lfs.2012.04.038","article-title":"Sortilin is required for toxic action of Abeta oligomers (AbetaOs): Extracellular AbetaOs trigger apoptosis, and intraneuronal AbetaOs impair degradation pathways","volume":"91","author":"Takamura","year":"2012","journal-title":"Life Sci"},{"key":"10.3233\/JAD-179941_ref211","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","article-title":"Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer\u2019s disease","volume":"21","author":"Dineley","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref212","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"Beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref213","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1096\/fj.10-156661","article-title":"Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity","volume":"24","author":"Wang","year":"2010","journal-title":"FASEB J"},{"key":"10.3233\/JAD-179941_ref214","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1017\/S1462399411002134","article-title":"Neuronal receptors as targets for the action of amyloid-beta protein (Abeta) in the brain","volume":"14","author":"Patel","year":"2012","journal-title":"Expert Rev Mol Med"},{"key":"10.3233\/JAD-179941_ref215","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1073\/pnas.93.4.1710","article-title":"Zn2+ interaction with Alzheimer amyloid beta protein calcium channels","volume":"93","author":"Arispe","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref216","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.4771-07.2008","article-title":"Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P\/Q-type calcium currents","volume":"28","author":"Nimmrich","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref217","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2004-6305","article-title":"Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release","volume":"6","author":"Bobich","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref218","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/acs.analchem.6b04950","article-title":"Real-time analysis of binding events between different Abeta1-42 species and human Lilrb2 by dual polarization interferometry","volume":"89","author":"Hu","year":"2017","journal-title":"Anal Chem"},{"key":"10.3233\/JAD-179941_ref219","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1242077","article-title":"Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer\u2019s model","volume":"341","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-179941_ref220","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1471-4159.2010.06783.x","article-title":"Microglial activation depends on beta-amyloid conformation: Role of the formylpeptide receptor 2","volume":"114","author":"Heurtaux","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref221","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI66827","article-title":"FcgammaRIIb mediates amyloid-beta neurotoxicity and memory impairment in Alzheimer\u2019s disease","volume":"123","author":"Kam","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-179941_ref222","doi-asserted-by":"crossref","first-page":"15157","DOI":"10.1523\/JNEUROSCI.4081-14.2015","article-title":"The transient receptor potential melastatin 2 (TRPM2) channel contributes to beta-amyloid oligomer-related neurotoxicity and memory impairment","volume":"35","author":"Ostapchenko","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref223","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.M109.057182","article-title":"Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption","volume":"285","author":"Zhao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref224","doi-asserted-by":"crossref","first-page":"e17953","DOI":"10.1371\/journal.pone.0017953","article-title":"Tauopathic changes in the striatum of A53T alpha-synuclein mutant mouse model of Parkinson\u2019s disease","volume":"6","author":"Wills","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref225","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1471-4159.2007.04809.x","article-title":"Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration","volume":"103","author":"Vieira","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3940(96)12761-0","article-title":"A beta peptide enhances focal adhesion kinase\/Fyn association in a rat CNS nerve cell line","volume":"211","author":"Zhang","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-179941_ref227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/alzrt238","article-title":"Fyn kinase inhibition as a novel therapy for Alzheimer\u2019s disease","volume":"6","author":"Nygaard","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref228","doi-asserted-by":"crossref","first-page":"8501693","DOI":"10.1155\/2016\/8501693","article-title":"Current research therapeutic strategies for Alzheimer\u2019s disease treatment","volume":"2016","author":"Folch","year":"2016","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-179941_ref229","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","article-title":"Phosphorylation of tau by fyn: Implications for Alzheimer\u2019s disease","volume":"24","author":"Lee","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref230","doi-asserted-by":"crossref","first-page":"21945","DOI":"10.1074\/jbc.M116.738286","article-title":"Regulation of amyloid beta oligomer binding to neurons and neurotoxicity by the prion protein-mGluR5 complex","volume":"291","author":"Beraldo","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref231","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-179941_ref232","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0896-6273(01)00220-3","article-title":"CAKbeta\/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus","volume":"29","author":"Huang","year":"2001","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref233","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1523\/JNEUROSCI.1029-10.2010","article-title":"Proline-rich tyrosine kinase 2 regulates hippocampal long-term depression","volume":"30","author":"Hsin","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref234","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1523\/JNEUROSCI.4992-08.2010","article-title":"Postsynaptic clustering and activation of Pyk2 by PSD-95","volume":"30","author":"Bartos","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref235","doi-asserted-by":"crossref","first-page":"15592","DOI":"10.1038\/ncomms15592","article-title":"Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington\u2019s disease model","volume":"8","author":"Giralt","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-179941_ref236","doi-asserted-by":"crossref","first-page":"20130","DOI":"10.1074\/jbc.M102307200","article-title":"Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade","volume":"276","author":"Andreev","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref237","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/383547a0","article-title":"A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation","volume":"383","author":"Dikic","year":"1996","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref238","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.185.7.1253","article-title":"Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling","volume":"185","author":"Qian","year":"1997","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-179941_ref239","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.molimm.2010.03.009","article-title":"T cell receptor activation leads to two distinct phases of Pyk2 activation and actin cytoskeletal rearrangement in human T cells","volume":"47","author":"Collins","year":"2010","journal-title":"Mol Immunol"},{"key":"10.3233\/JAD-179941_ref240","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.0409227","article-title":"The T cell receptor-mediated phosphorylation of Pyk2 tyrosines 402 and 580 occurs via a distinct mechanism than other receptor systems","volume":"87","author":"Collins","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.3233\/JAD-179941_ref241","doi-asserted-by":"crossref","first-page":"33315","DOI":"10.1074\/jbc.M313527200","article-title":"RAFTK\/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref242","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00018-012-1039-9","article-title":"Na(+),K (+)-ATPase as a docking station: Protein-protein complexes of the Na(+),K (+)-ATPase","volume":"70","author":"Reinhard","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-179941_ref243","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.febslet.2009.10.024","article-title":"Membrane protein assembly into Nanodiscs","volume":"584","author":"Bayburt","year":"2010","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-179941_ref244","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mi.3.3.157","article-title":"Na+-K+\u2013ATPase-mediated signal transduction: From protein interaction to cellular function","volume":"3","author":"Xie","year":"2003","journal-title":"Mol Interv"},{"key":"10.3233\/JAD-179941_ref245","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s12035-014-8975-3","article-title":"Functional interaction between Na\/K-ATPase and NMDA receptor in cerebellar neurons","volume":"52","author":"Akkuratov","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-179941_ref246","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-62703-275-9_18","article-title":"Nanodiscs as a new tool to examine lipid-protein interactions","volume":"974","author":"Schuler","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JAD-179941_ref247","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.neurobiolaging.2011.12.005","article-title":"Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref248","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s beta-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab"},{"key":"10.3233\/JAD-179941_ref249","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1474-9726.2012.00848.x","article-title":"Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-beta oligomers","volume":"11","author":"Costa","year":"2012","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-179941_ref250","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neurobiolaging.2014.09.006","article-title":"Abeta and NMDAR activation cause mitochondrial dysfunction involving ER calcium release","volume":"36","author":"Ferreira","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref251","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/acel.12054","article-title":"Ca(2+)-dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid beta-treated astrocytes and in a model of Alzheimer\u2019s disease","volume":"12","author":"Alberdi","year":"2013","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-179941_ref252","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnagi.2015.00094","article-title":"Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer\u2019s disease","volume":"7","author":"De Felice","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-179941_ref253","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jnr.23510","article-title":"Small Abeta1-42 oligomer-induced membrane depolarization of neuronal and microglial cells: Role of N-methyl-D-aspartate receptors","volume":"93","author":"Morkuniene","year":"2015","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-179941_ref254","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bpj.2014.07.074","article-title":"Beta-amyloid oligomers activate apoptotic BAK pore for cytochrome c release","volume":"107","author":"Kim","year":"2014","journal-title":"Biophys J"},{"key":"10.3233\/JAD-179941_ref255","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1093\/hmg\/dds360","article-title":"Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-179941_ref256","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fncel.2015.00166","article-title":"How the Wnt signaling pathway protects from neurodegeneration: The mitochondrial scenario","volume":"9","author":"Arr\u00e1zola","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-179941_ref257","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.3892\/mmr.2017.7203","article-title":"Amyloid beta-42 induces neuronal apoptosis by targeting mitochondria","volume":"16","author":"Han","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.3233\/JAD-179941_ref258","doi-asserted-by":"crossref","first-page":"538979","DOI":"10.1155\/2013\/538979","article-title":"Letrozole potentiates mitochondrial and dendritic spine impairments induced by beta amyloid","volume":"2013","author":"Chang","year":"2013","journal-title":"J Aging Res"},{"key":"10.3233\/JAD-179941_ref259","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2015.11.015","article-title":"Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal cell death by inhibiting ERK-Drp1-mediated mitochondrial fragmentation","volume":"90","author":"Kim","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-179941_ref260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13041-016-0261-z","article-title":"Amyloid beta oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner","volume":"9","author":"Rui","year":"2016","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-179941_ref261","doi-asserted-by":"crossref","unstructured":"Mastroeni D , Nolz J , Khdour OM , Sekar S , Delvaux E , Cuyugan L , Liang WS , Hecht SM , Coleman PD (2018) Oligomeric amyloid \u03b2 preferentially targets neuronal and not glial mitochondrial-encoded mRNAs, Alzheimers Dement, doi: 10.1016\/j.jalz.2017.12.005","DOI":"10.1016\/j.jalz.2017.12.005"},{"key":"10.3233\/JAD-179941_ref262","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/alzrt217","article-title":"Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease","volume":"5","author":"Orr","year":"2013","journal-title":"Alzheimers Res Therapy"},{"key":"10.3233\/JAD-179941_ref263","first-page":"81","article-title":"Lysosomal storage diseases\u2014regulating neurodegeneration","volume":"9","author":"Onyenwoke","year":"2015","journal-title":"J Exp Neurosci"},{"key":"10.3233\/JAD-179941_ref264","doi-asserted-by":"crossref","first-page":"e21776","DOI":"10.7554\/eLife.21776","article-title":"Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer\u2019s disease neurons","volume":"6","author":"Tammineni","year":"2017","journal-title":"Elife"},{"key":"10.3233\/JAD-179941_ref265","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4161\/auto.30001","article-title":"Abeta1-42 monomers or oligomers have different effects on autophagy and apoptosis","volume":"10","author":"Guglielmotto","year":"2014","journal-title":"Autophagy"},{"key":"10.3233\/JAD-179941_ref266","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref267","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/aww042","article-title":"Rifampicin is a candidate preventive medicine against amyloid-beta and tau oligomers","volume":"139","author":"Umeda","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref268","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neuroscience.2014.08.013","article-title":"Mitogen-activated protein kinase signaling pathways are involved in regulating alpha7 nicotinic acetylcholine receptor-mediated amyloid-beta uptake in SH-SY5Y cells","volume":"278","author":"Yang","year":"2014","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-179941_ref269","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3233\/JAD-122455","article-title":"Intracellular localization of amyloid-beta peptide in SH-SY5Y neuroblastoma cells","volume":"37","author":"Zheng","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2741\/4304","article-title":"Critical analysis of Alzheimer\u2019s amyloid-beta toxicity to mitochondria","volume":"20","author":"Kaminsky","year":"2015","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.3233\/JAD-179941_ref271","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.chembiol.2014.03.014","article-title":"Direct observations of amyloid beta self-assembly in live cells provide insights into differences in the kinetics of Abeta(1-40) and Abeta(1-42) aggregation","volume":"21","author":"Esbjorner","year":"2014","journal-title":"Chem Biol"},{"key":"10.3233\/JAD-179941_ref272","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/acel.12521","article-title":"Amyloid beta-induced astrogliosis is mediated by beta1-integrin via NADPH oxidase 2 in Alzheimer\u2019s disease","volume":"15","author":"Wyssenbach","year":"2016","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-179941_ref273","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1523\/JNEUROSCI.3351-16.2017","article-title":"Astrocyte transforming growth factor beta 1 protects synapses against Abeta oligomers in Alzheimer\u2019s disease model","volume":"37","author":"Diniz","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref274","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10571-015-0268-5","article-title":"Insulin attenuates beta-amyloid-associated insulin\/Akt\/EAAT signaling perturbations in human astrocytes","volume":"36","author":"Han","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-179941_ref275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2017.10.011","article-title":"Astrocytic glutamatergic transporters are involved in Abeta-induced synaptic dysfunction","volume":"1678","author":"Huang","year":"2018","journal-title":"Brain Res"},{"key":"10.3233\/JAD-179941_ref276","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/bi401606f","article-title":"Rare individual amyloid-beta oligomers act on astrocytes to initiate neuronal damage","volume":"53","author":"Narayan","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref277","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1570159X12666140828214701","article-title":"Calcium-sensing receptors of human astrocyte-neuron teams: Amyloid-beta-driven mediators and therapeutic targets of Alzheimer\u2019s disease","volume":"12","author":"Dal Pra","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-179941_ref278","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/exnr.1997.6738","article-title":"Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer\u2019s disease","volume":"149","author":"DeWitt","year":"1998","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-179941_ref279","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1523\/JNEUROSCI.3024-08.2008","article-title":"Inflammatory response in the hippocampus of PS1M146L\/APP751SL mouse model of Alzheimer\u2019s disease: Age-dependent switch in the microglial phenotype from alternative to classic","volume":"28","author":"Jimenez","year":"2008","journal-title":"JNeurosci"},{"key":"10.3233\/JAD-179941_ref280","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer\u2019s disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179941_ref281","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/brain\/aww016","article-title":"Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology","volume":"139","author":"Spangenberg","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-179941_ref282","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.10.024","article-title":"Minocycline attenuates Abeta oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Abeta fibrils phagocytosis","volume":"609","author":"El-Shimy","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-179941_ref283","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer\u2019s amyloid-beta oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref284","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref285","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer Dorothy","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref286","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-179941_ref287","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-\u03b2","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref288","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Spires-Jones","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref289","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fncel.2015.00464","article-title":"Tau oligomers: The toxic player at synapses in Alzheimer\u2019s disease","volume":"9","author":"Guerrero-Munoz","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-179941_ref290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-beta and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-179941_ref291","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO J"},{"key":"10.3233\/JAD-179941_ref292","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","article-title":"Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers","volume":"34","author":"Frandemiche","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref293","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1083\/jcb.201701045","article-title":"Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Abeta1-42 synaptotoxicity","volume":"216","author":"Qu","year":"2017","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-179941_ref294","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","article-title":"Preparation and characterization of neurotoxic tau oligomers","volume":"49","author":"Lasagna-Reeves","year":"2010","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajpath.2015.09.018","article-title":"Synaptic amyloid-beta oligomers precede p-Tau and differentiate high pathology control cases","volume":"186","author":"Bilousova","year":"2016","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179941_ref296","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","article-title":"Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease","volume":"3","author":"Pooler","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-179941_ref297","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/alzrt214","article-title":"Propagation of tau pathology in Alzheimer\u2019s disease: Identification of novel therapeutic targets","volume":"5","author":"Pooler","year":"2013","journal-title":"Alzheimers Res Therapy"},{"key":"10.3233\/JAD-179941_ref298","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.neurobiolaging.2013.05.003","article-title":"Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer\u2019s disease","volume":"34","author":"Saul","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref299","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2013.09.010","article-title":"Increased misfolding and truncation of tau in APP\/PS1\/tau transgenic mice compared to mutant tau mice","volume":"62","author":"Heraud","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179941_ref300","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00401-014-1259-1","article-title":"Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice","volume":"127","author":"Umeda","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref301","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2014.01.007","article-title":"Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer\u2019s disease","volume":"64","author":"Chabrier","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179941_ref302","doi-asserted-by":"crossref","first-page":"e80706","DOI":"10.1371\/journal.pone.0080706","article-title":"Modeling Alzheimer\u2019s disease in mouse without mutant protein overexpression: Cooperative and independent effects of Abeta and tau","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref303","doi-asserted-by":"crossref","first-page":"e0153724","DOI":"10.1371\/journal.pone.0153724","article-title":"Humanized tau mice with regionalized amyloid exhibit behavioral deficits but no pathological interaction","volume":"11","author":"Yetman","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref304","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/19336896.2017.1334029","article-title":"Abeta seeds and prions: How close the fit?","volume":"11","author":"Rasmussen","year":"2017","journal-title":"Prion"},{"key":"10.3233\/JAD-179941_ref305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnmol.2016.00029","article-title":"Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion","volume":"9","author":"Espargaro","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-179941_ref306","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2013.12.019","article-title":"Spreading of amyloid-beta peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance","volume":"65","author":"Domert","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179941_ref307","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","article-title":"Seeding \u201cone-dimensional crystallization\u201d of amyloid: A pathogenic mechanism in Alzheimer\u2019s disease and scrapie?","volume":"73","author":"Jarrett","year":"1993","journal-title":"Cell"},{"key":"10.3233\/JAD-179941_ref308","doi-asserted-by":"crossref","first-page":"28125","DOI":"10.1038\/srep28125","article-title":"Highly potent intracellular membrane-associated Abeta seeds","volume":"6","author":"Marzesco","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-179941_ref309","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00702-005-0385-2","article-title":"Very long term studies of the seeding of beta-amyloidosis in primates","volume":"113","author":"Ridley","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-179941_ref310","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn.4117","article-title":"Persistence of Abeta seeds in APP null mouse brain","volume":"18","author":"Ye","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-179941_ref311","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ijms17020173","article-title":"Focus on extracellular vesicles: Exosomes and their role in protein trafficking and biomarker potential in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"17","author":"Vella","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-179941_ref312","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bpa.12252","article-title":"Progression of seed-induced Abeta deposition within the limbic connectome","volume":"25","author":"Ye","year":"2015","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-179941_ref313","doi-asserted-by":"crossref","first-page":"e1003956","DOI":"10.1371\/journal.pcbi.1003956","article-title":"Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders","volume":"10","author":"Iturria-Medina","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.3233\/JAD-179941_ref314","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2014.12.004","article-title":"Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases","volume":"36","author":"Ciryam","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-179941_ref315","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1371\/journal.pbio.0050290","article-title":"Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity","volume":"5","author":"Luheshi","year":"2007","journal-title":"PLoS Biol"},{"key":"10.3233\/JAD-179941_ref316","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.celrep.2013.09.043","article-title":"Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins","volume":"5","author":"Ciryam","year":"2013","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-179941_ref317","doi-asserted-by":"crossref","first-page":"E5703","DOI":"10.1073\/pnas.1618417114","article-title":"Protein homeostasis of a metastable subproteome associated with Alzheimer\u2019s disease","volume":"114","author":"Kundra","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref318","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-160027","article-title":"Shear-induced amyloid formation in the brain: I. Potential vascular and parenchymal processes","volume":"54","author":"Trumbore","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref319","doi-asserted-by":"crossref","first-page":"150ra122","DOI":"10.1126\/scitranslmed.3004291","article-title":"Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer\u2019s disease pathology","volume":"4","author":"Roh","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-179941_ref320","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref321","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","article-title":"Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease","volume":"93","author":"Peng","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179941_ref322","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI64595","article-title":"Alzheimer\u2019s disease and insulin resistance: Translating basic science into clinical applications","volume":"123","author":"De Felice","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-179941_ref323","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.arr.2016.11.003","article-title":"Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders","volume":"34","author":"Ikonomovic","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-179941_ref324","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.rehab.2017.03.009","article-title":"Association of traumatic brain injury and Alzheimer disease onset: A systematic review","volume":"60","author":"Julien","year":"2017","journal-title":"Ann Phys Rehabil Med"},{"key":"10.3233\/JAD-179941_ref325","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","article-title":"Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans","volume":"22","author":"Johnson","year":"2012","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-179941_ref326","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jalz.2014.04.006","article-title":"Cognitive changes and dementia risk after traumatic brain injury: Implications for aging military personnel.S","volume":"10","author":"Vincent","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179941_ref327","doi-asserted-by":"crossref","unstructured":"Abu Hamdeh S , Waara ER , Moller C , Soderberg L , Basun H , Alafuzoff I , Hillered L , Lannfelt L , Ingelsson M , Marklund N (2017) Rapid amyloid-beta oligomer and protofibril accumulation in traumatic brain injury, Brain Pathol. doi: 10.1111\/bpa.12532","DOI":"10.1111\/bpa.12532"},{"key":"10.3233\/JAD-179941_ref328","first-page":"1336","article-title":"Detection of beta-amyloid oligomers as a predictor of neurological outcome after brain injury","volume":"118","author":"Gatson","year":"2013","journal-title":"JNeurosurg"},{"key":"10.3233\/JAD-179941_ref329","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jocn.2009.07.001","article-title":"Diffuse neuronal perikaryal amyloid precursor protein immunoreactivity in an ovine model of non-accidental head injury (the shaken baby syndrome)","volume":"17","author":"Finnie","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JAD-179941_ref330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5858\/2000-124-0251-ONDISB","article-title":"Optic nerve damage in shaken baby syndrome: Detection by beta-amyloid precursor protein immunohistochemistry","volume":"124","author":"Gleckman","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.3233\/JAD-179941_ref331","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5858\/1999-123-0146-DAIIIW","article-title":"Diffuse axonal injury in infants with nonaccidental craniocerebral trauma: Enhanced detection by beta-amyloid precursor protein immunohistochemical staining","volume":"123","author":"Gleckman","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.3233\/JAD-179941_ref332","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1523\/JNEUROSCI.0858-11.2011","article-title":"Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities","volume":"31","author":"Tran","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref333","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/neu.2013.3017","article-title":"Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer\u2019s disease mouse model","volume":"31","author":"Washington","year":"2014","journal-title":"JNeurotrauma"},{"key":"10.3233\/JAD-179941_ref334","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.expneurol.2005.10.020","article-title":"Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury","volume":"197","author":"Brody","year":"2006","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-179941_ref335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40478-017-0435-7","article-title":"Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein","volume":"5","author":"Rubenstein","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-179941_ref336","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/jnc.12395","article-title":"Urban air pollutants reduce synaptic function of CA1 neurons via an NMDA\/NO pathway in vitro","volume":"127","author":"Davis","year":"2013","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-179941_ref337","doi-asserted-by":"crossref","first-page":"e64128","DOI":"10.1371\/journal.pone.0064128","article-title":"Prenatal exposure to urban air nanoparticles in mice causes altered neuronal differentiation and depression-like responses","volume":"8","author":"Davis","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref338","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-016-0480-3","article-title":"Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFalpha in vitro","volume":"13","author":"Cheng","year":"2016","journal-title":"JNeuroinflammation"},{"key":"10.3233\/JAD-179941_ref339","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.freeradbiomed.2012.02.042","article-title":"Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments","volume":"52","author":"Zhang","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-179941_ref340","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3945\/an.115.011775","article-title":"Associations between sleep, cortisol regulation, and diet: Possible implications for the risk of Alzheimer disease","volume":"7","author":"Pistollato","year":"2016","journal-title":"Adv Nutr"},{"key":"10.3233\/JAD-179941_ref341","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1326-4-40","article-title":"Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer\u2019s amyloid pathology","volume":"4","author":"Pedrini","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-179941_ref342","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hipo.20470","article-title":"Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats","volume":"18","author":"Stranahan","year":"2008","journal-title":"Hippocampus"},{"key":"10.3233\/JAD-179941_ref343","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","article-title":"Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-beta oligomers in mice","volume":"64","author":"Kincheski","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-179941_ref344","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","article-title":"Type 3 diabetes is sporadic Alzheimers disease: Mini-review","volume":"24","author":"de la Monte","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3233\/JAD-179941_ref345","doi-asserted-by":"crossref","first-page":"18036","DOI":"10.1039\/C7CP02849K","article-title":"Glucose directs amyloid-beta into membrane-active oligomers","volume":"19","author":"Kedia","year":"2017","journal-title":"Phys Chem Chem Phys"},{"key":"10.3233\/JAD-179941_ref346","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2012-120571","article-title":"Amyloid-beta and tau pathology of Alzheimer\u2019s disease induced by diabetes in a rabbit animal model","volume":"32","author":"Bitel","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref347","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.dadm.2017.11.002","article-title":"Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer\u2019s disease biomarker amyloid beta1-42 in Alzheimer\u2019s Disease Neuroimaging Initiative participants","volume":"10","author":"Li","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-179941_ref348","doi-asserted-by":"crossref","first-page":"282","DOI":"10.14336\/AD.2014.002","article-title":"Metabolic risk factors of sporadic Alzheimer\u2019s disease: Implications in the pathology, pathogenesis and treatment","volume":"6","author":"Chakrabarti","year":"2015","journal-title":"Aging Dis"},{"key":"10.3233\/JAD-179941_ref349","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2016.02.024","article-title":"Imbalanced cholesterol metabolism in Alzheimer\u2019s disease","volume":"456","author":"Xue-Shan","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-179941_ref350","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.lfs.2011.12.022","article-title":"Hypercholesterolemia accelerates intraneuronal accumulation of Abeta oligomers resulting in memory impairment in Alzheimer\u2019s disease model mice","volume":"91","author":"Umeda","year":"2012","journal-title":"Life Sci"},{"key":"10.3233\/JAD-179941_ref351","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.1051-10.2010","article-title":"Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice","volume":"30","author":"Fitz","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref352","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/ijms17030338","article-title":"Amyloid-beta and astrocytes interplay in amyloid-beta related disorders","volume":"17","author":"Batarseh","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-179941_ref353","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/glia.21004","article-title":"Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins","volume":"58","author":"Nielsen","year":"2010","journal-title":"Glia"},{"key":"10.3233\/JAD-179941_ref354","first-page":"7","article-title":"Metabolic dysfunction of astrocyte: An initiating factor in beta-amyloid pathology?","volume":"1","author":"Yan","year":"2013","journal-title":"Aging Neurodegener"},{"key":"10.3233\/JAD-179941_ref355","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.expneurol.2009.10.013","article-title":"Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain","volume":"223","author":"Perez","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-179941_ref356","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1073858414529828","article-title":"Do astrocytes collaborate with neurons in spreading the \u201cinfectious\u201d abeta and Tau drivers of Alzheimer\u2019s disease?","volume":"21","author":"Dal Pra","year":"2015","journal-title":"Neuroscientist"},{"key":"10.3233\/JAD-179941_ref357","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jalz.2013.12.004","article-title":"How does brain insulin resistance develop in Alzheimer\u2019s disease?","volume":"10","author":"De Felice","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179941_ref358","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-179941_ref359","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2017.10.012","article-title":"Neuroprotective effects of a triple GLP-1\/GIP\/glucagon receptor agonist in the APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease","volume":"1678","author":"Tai","year":"2018","journal-title":"Brain Res"},{"key":"10.3233\/JAD-179941_ref360","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: A beginner\u2019s guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-179941_ref361","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3233\/JAD-170032","article-title":"Cerebrospinal fluid amyloid-beta levels are increased in patients with insomnia","volume":"61","author":"Chen","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref362","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/1673-5374.180372","article-title":"The choroid plexus-cerebrospinal fluid interface in Alzheimer\u2019s disease: More than just a barrier","volume":"11","author":"Balusu","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-179941_ref363","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1523\/JNEUROSCI.0006-15.2015","article-title":"Amyloid beta oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases","volume":"35","author":"Brkic","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref364","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref365","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref366","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1523\/JNEUROSCI.0172-12.2012","article-title":"Soluble abeta promotes wild-type tau pathology in vivo","volume":"32","author":"Chabrier","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref367","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric abeta, and frank neuronal loss","volume":"33","author":"Cohen","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref368","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","article-title":"\u2018Too much good news\u2019 - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer\u2019s disease?","volume":"33","author":"Zahs","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-179941_ref369","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer\u2019s disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J"},{"key":"10.3233\/JAD-179941_ref370","first-page":"1423","article-title":"Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer\u2019s disease","volume":"138","author":"Podlisny","year":"1991","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179941_ref371","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.12.005","article-title":"Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition","volume":"1315","author":"Oikawa","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-179941_ref372","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0197-4580(00)00176-7","article-title":"Age-related progression of tau pathology in brains of baboons","volume":"21","author":"Schultz","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref373","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0798-827","article-title":"Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity","volume":"4","author":"Geula","year":"1998","journal-title":"Nat Med"},{"key":"10.3233\/JAD-179941_ref374","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neurobiolaging.2009.02.025","article-title":"Microglia activation mediates fibrillar amyloid-beta toxicity in the aged primate cortex","volume":"32","author":"Leung","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref375","unstructured":"Boehnke SE , Wither RG , Nashed JY , Cook DJ , Levy R , De Felice FG , Munoz DP (2017) Changes in cerebrospinal fluid and neuroimaging biomarkers in a non-human primate model of Alzheimer\u2019s Disease, Society for Neuroscience, Washington, DC, Presentation 356.04."},{"key":"10.3233\/JAD-179941_ref376","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JAD-179941_ref377","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","article-title":"Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation","volume":"9","author":"Ochalek","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref378","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nprot.2015.065","article-title":"A 3D human neural cell culture system for modeling Alzheimer\u2019s disease","volume":"10","author":"Kim","year":"2015","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-179941_ref379","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.neuron.2017.02.001","article-title":"Hallmarks of Alzheimer\u2019s disease in stem-cell-derived human neurons transplanted into mouse brain","volume":"93","author":"Espuny-Camacho","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-179941_ref380","first-page":"91","article-title":"Octodon degus: A strong attractor for Alzheimer research","volume":"4","author":"Castro-Fuentes","year":"2013","journal-title":"Basic Clin Neurosci"},{"key":"10.3233\/JAD-179941_ref381","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cns.12125","article-title":"Octodon degus: A model for the cognitive impairment associated with Alzheimer\u2019s disease","volume":"19","author":"Tarragon","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-179941_ref382","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1167\/iovs.13-12888","article-title":"Ocular changes in TgF344-AD rat model of Alzheimer\u2019s disease","volume":"55","author":"Tsai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.3233\/JAD-179941_ref383","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-130212","article-title":"AbetaPP-overexpressing transgenic rat model of Alzheimer\u2019s disease utilizing the Tg2576 mouse protocol","volume":"37","author":"O\u2019Hare","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref384","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/2051-5960-2-61","article-title":"Intracellular Abeta pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: A multidimensional study","volume":"2","author":"Iulita","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-179941_ref385","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3233\/JAD-142802","article-title":"Drosophila models of Alzheimer\u2019s disease: Advances, limits, and perspectives","volume":"45","author":"Bouleau","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref386","doi-asserted-by":"crossref","first-page":"e106068","DOI":"10.1371\/journal.pone.0106068","article-title":"Relationships between the circadian system and Alzheimer\u2019s disease-like symptoms in Drosophila","volume":"9","author":"Long","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref387","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fgene.2014.00279","article-title":"Use of Caenorhabditis elegans as a model to study Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"5","author":"Alexander","year":"2014","journal-title":"Front Genet"},{"key":"10.3233\/JAD-179941_ref388","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.nbd.2010.07.002","article-title":"Tetracycline and its analogues protect Caenorhabditis elegans from beta amyloid-induced toxicity by targeting oligomers","volume":"40","author":"Diomede","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-179941_ref389","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neurobiolaging.2008.07.013","article-title":"Heat shock treatment reduces beta amyloid toxicity in vivo by diminishing oligomers","volume":"31","author":"Wu","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref390","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1523\/JNEUROSCI.2912-14.2015","article-title":"Stabilization of nontoxic Abeta-oligomers: Insights into the mechanism of action of hydroxyquinolines in Alzheimer\u2019s disease","volume":"35","author":"Ryan","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref391","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1326-7-57","article-title":"Utility of an improved model of amyloid-beta (Abeta(1)(-)(4)(2)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer\u2019s disease","volume":"7","author":"McColl","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-179941_ref392","doi-asserted-by":"crossref","first-page":"13680","DOI":"10.1073\/pnas.1414554111","article-title":"Toward a unified therapeutics approach targeting putative amyloid-beta oligomer receptors","volume":"111","author":"Overk","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref393","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer\u2019s disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-179941_ref394","doi-asserted-by":"crossref","first-page":"P326","DOI":"10.1016\/j.jalz.2013.04.166","article-title":"ACU-193: A candidate therapeutic antibody that selectively targets soluble beta-amyloid oligomers","volume":"9","author":"Krafft","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-179941_ref395","first-page":"293","article-title":"Characterization of the selective in vivo and in vitro binding properties of crenezumab: Insights into crenezumab\u2019s unique mechanism of action","volume":"4","author":"Meilandt","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref396","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.3233\/JAD-179941_ref397","doi-asserted-by":"crossref","first-page":"30990","DOI":"10.1074\/jbc.M114.589069","article-title":"Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein","volume":"289","author":"Maloney","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref398","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-014-0089-7","article-title":"BACE1 inhibitor drugs in clinical trials for Alzheimer\u2019s disease","volume":"6","author":"Vassar","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref399","first-page":"155","article-title":"BACE inhibitor bust in Alzheimer trial","volume":"16","author":"Mullard","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-179941_ref400","doi-asserted-by":"crossref","first-page":"8631","DOI":"10.1073\/pnas.1708106114","article-title":"BACE inhibition-dependent repair of Alzheimer\u2019s pathophysiology","volume":"114","author":"Keskin","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref401","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-179941_ref402","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.0000000000000364","article-title":"Clinical trial of an inhibitor of RAGE-Abeta interactions in Alzheimer disease","volume":"82","author":"Galasko","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-179941_ref403","first-page":"317","article-title":"The anti-AB oligomer drug CT1812 for Alzheimer\u2019s: Phase 1B\/2A safety trial outcomes","volume":"4","author":"Schneider","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref404","first-page":"401","article-title":"Biomarker outcomes from the phase 1b\/2a safety trial of the anti-AB oligomer drug CT1812 in Alzheimer\u2019s patients","volume":"4","author":"Catalano","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref405","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower Abeta accumulation by targeting both the production and the clearance of Abeta across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol Med"},{"key":"10.3233\/JAD-179941_ref406","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/1568026615666150813142423","article-title":"Targeting insulin signaling for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Chen","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.3233\/JAD-179941_ref407","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db14-0287","article-title":"Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease","volume":"63","author":"Yarchoan","year":"2014","journal-title":"Diabetes"},{"issue":"Pt A","key":"10.3233\/JAD-179941_ref408","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-179941_ref409","doi-asserted-by":"crossref","first-page":"e1168557","DOI":"10.1080\/2162402X.2016.1168557","article-title":"Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors","volume":"5","author":"Cheng","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.3233\/JAD-179941_ref410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","article-title":"Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus","volume":"79","author":"Kuan","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-179941_ref411","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","article-title":"Targeting fyn kinase in Alzheimer\u2019s disease","volume":"83","author":"Nygaard","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-179941_ref412","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ana.24394","article-title":"Fyn inhibition rescues established memory and synapse loss in Alzheimer mice","volume":"77","author":"Kaufman","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-179941_ref413","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","article-title":"Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance","volume":"92","author":"Lonskaya","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"10.3233\/JAD-179941_ref414","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JPD-160867","article-title":"Nilotinib effects in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-179941_ref415","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40265-015-0529-0","article-title":"Tau biology and tau-directed therapies for Alzheimer\u2019s disease","volume":"76","author":"Bakota","year":"2016","journal-title":"Drugs"},{"key":"10.3233\/JAD-179941_ref416","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: A randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.3233\/JAD-179941_ref417","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer\u2019s disease: Cohort analysis as modified primary outcome in a phase III clinical trial","volume":"61","author":"Wilcock","year":"2018","journal-title":"JAlzheimers Dis"},{"key":"10.3233\/JAD-179941_ref418","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jalz.2016.02.007","article-title":"Challenges, solutions, and recommendations for Alzheimer\u2019s disease combination therapy","volume":"12","author":"Hendrix","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.3233\/JAD-179941_ref419","first-page":"825","article-title":"Phase II study to assess safety and target engagement of AMX0035, a novel combination therapy, in Alzheimer\u2019s disease","volume":"14","author":"Leslie","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-179941_ref420","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1074\/jbc.M114.586602","article-title":"A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid beta in the brain in a transgenic model of Alzheimer disease","volume":"290","author":"Hori","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-179941_ref421","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00207454.2016.1155572","article-title":"Alzheimer\u2019s disease and diet: A systematic review","volume":"127","author":"Yusufov","year":"2017","journal-title":"Int J Neurosci"},{"key":"10.3233\/JAD-179941_ref422","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-130830","article-title":"Association of mediterranean diet with mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"39","author":"Singh","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref423","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1017\/S0007114517003452","article-title":"Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: A 10-year systematic review of randomised controlled trials","volume":"119","author":"D\u2019Cunha","year":"2018","journal-title":"Br J Nutr"},{"key":"10.3233\/JAD-179941_ref424","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1096\/fj.10-175976","article-title":"High ability of apolipoprotein E4 to stabilize amyloid-beta peptide oligomers, the pathological entities responsible for Alzheimer\u2019s disease","volume":"25","author":"Cerf","year":"2011","journal-title":"FASEB J"},{"key":"10.3233\/JAD-179941_ref425","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/bi5008172","article-title":"The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation","volume":"53","author":"Garai","year":"2014","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-179941_ref426","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bios.2015.05.017","article-title":"Label-free detection of ApoE4-mediated beta-amyloid aggregation on single nanoparticle uncovering Alzheimer\u2019s disease","volume":"72","author":"Kang","year":"2015","journal-title":"Biosens Bioelectron"},{"key":"10.3233\/JAD-179941_ref427","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1073\/pnas.1018381108","article-title":"C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice","volume":"108","author":"Bien-Ly","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-179941_ref428","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.neurobiolaging.2006.05.024","article-title":"Abeta42 neurotoxicity in primary co-cultures: Effect of apoE isoform and Abeta conformation","volume":"28","author":"Manelli","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref429","first-page":"75","article-title":"Blocking the apoE\/Abeta interaction ameliorates Abeta-related pathology in APOE epsilon2 and epsilon4 targeted replacement Alzheimer model mice","volume":"2","author":"Pankiewicz","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-179941_ref430","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref431","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/026010600601800307","article-title":"Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Cole","year":"2006","journal-title":"Nutr Health"},{"key":"10.3233\/JAD-179941_ref432","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jamaneurol.2016.4899","article-title":"Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E epsilon4 carriers: A review","volume":"74","author":"Yassine","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-179941_ref433","first-page":"733","article-title":"Physical activity and Alzheimer\u2019s disease: A systematic review","volume":"72","author":"Stephen","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-179941_ref434","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-5-13","article-title":"Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid","volume":"5","author":"Nichol","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-179941_ref435","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1523\/JNEUROSCI.0496-05.2005","article-title":"Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer\u2019s disease","volume":"25","author":"Adlard","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-179941_ref436","doi-asserted-by":"crossref","first-page":"e1006962","DOI":"10.1371\/journal.pgen.1006962","article-title":"A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer\u2019s disease","volume":"13","author":"Rocchi","year":"2017","journal-title":"PLoS Genet"},{"key":"10.3233\/JAD-179941_ref437","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bpa.12255","article-title":"Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer\u2019s disease","volume":"26","author":"Tapia-Rojas","year":"2016","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-179941_ref438","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2014.00001","article-title":"Environmental enrichment strengthens corticocortical interactions and reduces amyloid-beta oligomers in aged mice","volume":"6","author":"Mainardi","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-179941_ref439","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1474-4422(04)00767-7","article-title":"An active and socially integrated lifestyle in late life might protect against dementia","volume":"3","author":"Fratiglioni","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-179941_ref440","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/aje\/155.12.1081","article-title":"Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: A longitudinal study from the Kungsholmen project","volume":"155","author":"Wang","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JAD-179941_ref441","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000089919","article-title":"Mental, physical and social components in leisure activities equally contribute to decrease dementia risk","volume":"21","author":"Karp","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-179941_ref442","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-017-0324-0","article-title":"Oligomeric forms of amyloid-beta protein in plasma as a potential blood-based biomarker for Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-179941_ref443","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnins.2015.00345","article-title":"The past and the future of Alzheimer\u2019s disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events","volume":"9","author":"Blennow","year":"2015","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-179941_ref444","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ajpath.2017.11.011","article-title":"Discrete pools of oligomeric amyloid-beta track with spatial learning deficits in a mouse model of Alzheimer amyloidosis","volume":"188","author":"Chiang","year":"2018","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-179941_ref445","doi-asserted-by":"crossref","first-page":"825 e821","DOI":"10.1016\/j.neurobiolaging.2011.05.003","article-title":"Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity","volume":"33","author":"Bao","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-179941_ref446","doi-asserted-by":"crossref","first-page":"0174630","DOI":"10.1371\/journal.pone.0174630","article-title":"Abeta levels in the jugular vein and high molecular weight Abeta oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer\u2019s disease.e","volume":"12","author":"Kasai","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JAD-179941_ref447","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3233\/JAD-122107","article-title":"In vivo and ex vivo imaging of amyloid-beta cascade aggregates with a Pronucleon peptide","volume":"34","author":"Nyborg","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-179941_ref448","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00401-015-1435-y","article-title":"Beta-amyloid deposition in chronic traumatic encephalopathy","volume":"130","author":"Stein","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref449","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00401-010-0737-3","article-title":"Novel demonstration of amyloid-beta oligomers in sporadic inclusion-body myositis muscle fibers","volume":"120","author":"Nogalska","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-179941_ref450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mehy.2008.01.030","article-title":"Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma","volume":"71","author":"Yin","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-179941_ref451","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2016.02.002","article-title":"TGF-beta1 prevents rat retinal insult induced by amyloid-beta (1-42) oligomers","volume":"787","author":"Fisichella","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-179941_ref452","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1167\/iovs.06-0738","article-title":"RAGE ligand upregulation of VEGF secretion in ARPE-19 cells","volume":"48","author":"Ma","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.3233\/JAD-179941_ref453","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1167\/iovs.09-4207","article-title":"Soluble and mature amyloid fibrils in drusen deposits","volume":"51","author":"Isas","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.3233\/JAD-179941_ref454","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2014.12.038","article-title":"MRZ-99030 - A novel modulator of Abeta aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer\u2019s disease, glaucoma and age-related macular degeneration (AMD)","volume":"92","author":"Parsons","year":"2015","journal-title":"Neuropharmacology"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-179941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:41Z","timestamp":1777370861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-179941"}},"subtitle":[],"editor":[{"given":"G.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"J.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"P.I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"A.A.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"M.","family":"Tabaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":454,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-179941","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}